Journal article
Novel synthetic, host-defense peptide protects against organ injury/dysfunction in a rat model of severe hemorrhagic shock
- Abstract:
-
Objective: To evaluate (1) levels of the host-defense/antimicrobial peptide LL-37 in patients with trauma and hemorrhagic shock (HS) and (2) the effects of a synthetic host-defense peptide; Pep19-4LF on multiple organ failure (MOF) associated with HS.
Background: HS is a common cause of death in severely injured patients. There is no specific therapy that reduces HS-associated MOF.
Methods: (1) LL-37 was measured in 47 trauma/HS patients admitted to an urban major trauma center. (2) Male Wistar rats were submitted to HS (90 min, target mean arterial pressure: 27–32 mm Hg) or sham operation. Rats were treated with Pep19-4LF [66 (n = 8) or 333 μg/kg · h (n = 8)] or vehicle (n = 12) for 4 hours following resuscitation.
Results: Plasma LL-37 was 12-fold higher in patients with trauma/HS compared to healthy volunteers. HS rats treated with Pep19-4LF (high dose) had a higher mean arterial pressure at the end of the 4-hour resuscitation period (79 ± 4 vs 54 ± 5 mm Hg) and less renal dysfunction, liver injury, and lung inflammation than HS rats treated with vehicle. Pep19-4LF enhanced (kidney/liver) the phosphorylation of (1) protein kinase B and (2) endothelial nitric oxide synthase. Pep19-4LF attenuated the HS-induced (1) translocation of p65 from cytosol to nucleus, (2) phosphorylation of IκB kinase on Ser176/180, and (3) phosphorylation of IκBα on Ser32/36 resulting in inhibition of nuclear factor kappa B and formation of proinflammatory cytokines. Pep19-4LF prevented the release of tumor necrosis factor alpha caused by heparan sulfate in human mononuclear cells by binding to this damage-associated molecular pattern.
Conclusions: Trauma-associated HS results in release of LL-37. The synthetic host-defense/antimicrobial peptide Pep19-4LF attenuates the organ injury/dysfunction associated with HS.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 490.0KB, Terms of use)
-
- Publisher copy:
- 10.1097/sla.0000000000002186
Authors
- Publisher:
- Wolters Kluwer
- Journal:
- Annals of Surgery More from this journal
- Volume:
- 268
- Issue:
- 2
- Pages:
- 348-356
- Publication date:
- 2018-08-01
- Acceptance date:
- 2017-03-14
- DOI:
- EISSN:
-
1528-1140
- ISSN:
-
0003-4932
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:977305
- UUID:
-
uuid:2b4cbefd-82a5-4e33-9a57-10f0342d139f
- Local pid:
-
pubs:977305
- Source identifiers:
-
977305
- Deposit date:
-
2019-07-18
- ARK identifier:
Terms of use
- Copyright holder:
- Wolters Kluwer
- Copyright date:
- 2018
- Notes:
- © 2017 Wolters Kluwer Health, Inc. All rights reserved. This is the accepted manuscript version of the article. The final version is available online from Wolters Kluwer at: https://doi.org/10.1097/sla.0000000000002186
If you are the owner of this record, you can report an update to it here: Report update to this record